Chennai: Medall Diagnostics, India’s leading integrated diagnostic services provider, today announced the revoking of the suspension of its license vide R. No. 48051/Epi/S3/2021 dated 28.05.2021, from Director of Public Health & Preventive Medicine, Govt. of Tamilnadu. The original suspension was issued by the same department under Notice No. 48051/Epi/S3/2021 dated May 21, 2021. The inspection team which visited the premises found the testing process to be satisfactory and the entire lab to be following all set guidelines. It advised Medall to have its staff at the lab vaccinated and to ensure the data with ICMR gets updated with the corrected data. ICMR database has since been updated with the correct data and most staff at the lab vaccinated with the rest to be completed contingent to vaccine availability. Medall has added a layer of supervision to avoid such clerical error while inputting test data into the ICMR servers, in the future which was also a recommendation of the inspection committee.
In his comments, Arjun Ananth, CEO, Medall, said “I am relieved to see our testing process rigor and sanctity validated and there being nothing to prove the alleged nexus between Medall and any hospital. We are among the largest private players doing RT-PCR, antigen and anti-body tests in Tamilnadu and we will continue to be active & proud partners in the state government’s efforts to contain the pandemic.”
“Would like to reiterate and bring public attention to the fact that its Medall and its management which argued in public interest to bring down the cost of RT-PCR testing and who infact proactively reduced the pricing before any other industry player to make it affordable and accessible for more citizens. We launched a package called “Back to work”, to create a healthy and safe workplace and have partnered large NGOs and corporates to help them in restarting their factories and offices. Over and above this, we have also partnered various Siddha Institutes to evaluate the efficacy of Siddha medicine in treating COVID-19,” he further added.
About Medall: Medall is India's fastest growing integrated Healthcare Diagnostics and the fourth largest Diagnostics, player in India. With 7000+ customer touch points across 9 states and 70+ districts, 24 NABL accredited labs and 108 ISO Certified Labs, Medall provides both radiology and pathology services under one roof. Medall serves over 10 million customers and performes over 30 million tests annually. With a strong focus on digitisation and deployment of state-of-the-art technology, Medall is pioneering clinical and technological innovations in diagnostics. To know more please log on to: https://www.medall.in
Bengaluru, May 05, 2024
Indian National Space Promotion and
Bengaluru, India – May 02, 2024 – Agora, Inc.
Gurugram, India – October 11, 2023: Samsung announced exciting offers
Bangalore, 10th October 2023: The Nokia G42 5G (16GB+256G
Bengaluru, 8 May 2024: As Akshaya Tritiya approaches, the anticipation for new beginnings and prosperity fills the air.
India – April 30, 2024 – Solitario, the premier destination for luxury lab-grown diamo
Mumbai - National, 29th April 2024: Greenply Industries Limited, a pioneer in the interior infrastructu